UniProt/SwissProt ID: | CRKL_HUMAN |
Description: | v-crk sarcoma virus CT10 oncogene homolog (avian)-like [Source:HGNC Symbol;Acc:2363] |
Location: | chr22 q11.21 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
Y251 | RVPCAyDKTAL | HPRD; RegPhos | |
S42 | LVRDSsTCPGD | SH2 | PhosphoSitePlus |
Y132 | YVRTLyDFPGN | HPRD; RegPhos; SysPTM | |
S232 | ITPLPsTQNGP | PhosphoSitePlus | |
S42 | LVRDSsTCPGD | HPRD | |
Y132 | YVRTLyDFPGN | SH3_1 | PhosphoSitePlus; SysPTM |
Y198 | RNSNSyGIPEP | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
T254 | CAYDKtALALE | SH3_2 | PhosphoSitePlus |
T130 | LEYVRtLYDFP | SH3_1 | PhosphoSitePlus |
T212 | YAQPQtTTPLP | PhosphoSitePlus; HPRD; phosphoELM | |
T43 | VRDSStCPGDY | SH2 | PhosphoSitePlus |
T96 | HYLDTtTLIEP | PhosphoSitePlus | |
Y207 | EPAHAyAQPQT | PhosphoSitePlus; HPRD; RegPhos | |
S222 | PAVSGsPGAAI | PhosphoSitePlus; HPRD | |
Y92 | FYKIHyLDTTT | PhosphoSitePlus | |
T95 | IHYLDtTTLIE | PhosphoSitePlus | |
Y207 | EPAHAyAQPQT | ABL1 | RegPhos |
S41 | FLVRDsSTCPG | HPRD | |
T43 | VRDSStCPGDY | HPRD | |
T213 | AQPQTtTPLPA | PhosphoSitePlus | |
Y251 | RVPCAyDKTAL | SH3_2 | PhosphoSitePlus |
S114 | PMGSVsAPNLP | PhosphoSitePlus | |
T214 | QPQTTtPLPAV | PhosphoSitePlus | |
T228 | PGAAItPLPST | PhosphoSitePlus | |
S195 | HGNRNsNSYGI | PhosphoSitePlus; HPRD | |
S107 | APRYPsPPMGS | PhosphoSitePlus; HPRD; RegPhos | |
Y207 | EPAHAyAQPQT | Abl | phosphoELM |
S220 | PLPAVsGSPGA | PhosphoSitePlus | |
S184 | EKLVRsSPHGK | PhosphoSitePlus; HPRD | |
Y48 | TCPGDyVLSVS | SH2 | PhosphoSitePlus |
S197 | NRNSNsYGIPE | PhosphoSitePlus; HPRD; phosphoELM | |
Y127 | EDNLEyVRTLY | PhosphoSitePlus | |
Dephosphorylation site |
CRKL_HUMAN do not have dephosphorylation site. |
Mutation site |
CRKL_HUMAN do not have mutation site. |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000396646 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 21 hour) | cell line | Down | 0.46 | 15169874 |
Hyperphosphorylation site |
CRKL_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
ABL1_HUMAN | CRKL_HUMAN | kinase -> substrate | RegPhos |
ZAGL2_HUMAN | CRKL_HUMAN | kinase -> substrate | RegPhos |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04062 | Chemokine signaling pathway |
hsa05220 | Chronic myeloid leukemia |
hsa05200 | Pathways in cancer |
hsa04910 | Insulin signaling pathway |
hsa04012 | ErbB signaling pathway |
hsa04722 | Neurotrophin signaling pathway |
hsa04810 | Regulation of actin cytoskeleton |
hsa05100 | Bacterial invasion of epithelial cells |
hsa05131 | Shigellosis |
hsa04510 | Focal adhesion |
hsa04010 | MAPK signaling pathway |
hsa05211 | Renal cell carcinoma |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0048538 | thymus development | IEA | biological_process |
GO:0007389 | pattern specification process | IEA | biological_process |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0009952 | anterior/posterior pattern specification | IEA | biological_process |
GO:0005070 | SH3/SH2 adaptor activity | TAS | molecular_function |
GO:0007254 | JNK cascade | TAS | biological_process |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0035556 | intracellular signal transduction | TAS | biological_process |
GO:0007265 | Ras protein signal transduction | TAS | biological_process |
GO:0007507 | heart development | IEA | biological_process |
GO:0009887 | organ morphogenesis | IEA | biological_process |
GO:0001568 | blood vessel development | IEA | biological_process |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0060017 | parathyroid gland development | IEA | biological_process |
GO:0004871 | signal transducer activity | TAS | molecular_function |